QUALIGEN
Qualigen is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as the expansion of its flagship FastPackยฎ diagnostic platform.
QUALIGEN
Industry:
Biotechnology
Founded:
1996-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.qualigeninc.com
Total Employee:
11+
Status:
Active
Contact:
760-579-6900
Total Funding:
30.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Origin Agritech
Origin Agritech is a leading agricultural biotechnology company.
Septerna
Septerna is a biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-03 | Nanosynex | Nanosynex acquired by Qualigen | N/A |
| 2020-05-26 | Ritter Pharmaceuticals | Ritter Pharmaceuticals acquired by Qualigen | N/A |
Key Employee Changes
Official Site Inspections
http://www.qualigeninc.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Qualigen"
Qualigen - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 760-579-6900 Qualigen is a biotechnology company focused on the development and commercialization of novel โฆSee details»
Our Company - Qualigen Therapeutics
Change Qualigen aims to change the status quo. Qualigen delivers change through science for life. Create Qualigen Therapeutics strives to create treatments that propel hope and improved outcomes. We enable patients for โฆSee details»
Home - Qualigen Therapeutics
Our Approach Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. We have three investigational oncology โฆSee details»
Qualigen Diagnostics - Home of the FastPack
Qualigen Therapeutics - LinkedIn
Qualigen Therapeutics | 1,393 followers on LinkedIn. Driven to Deliver | Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing โฆSee details»
Qualigen Company Profile - Office Locations, Competitors ... - Craft
See insights on Qualigen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce ... - Nasdaq
Jan 21, 2020 Management and Organization. ... Qualigen, Inc. (www.qualigeninc.com) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer โฆSee details»
Qualigen Therapeutics Engages TD2 as Contract Research โฆ
Mar 30, 2022 TD2 is a precision oncology drug development organization integrating preclinical, clinical, and regulatory expertise and providing expert drug development services, including โฆSee details»
Qualigen Therapeutics: Where It All Started And Where It's Going โฆ
Oct 8, 2022 In this episode of BioTech IQ, Ammon Rivera continues his exploration of Qualigen Therapeutics by interviewing the founder and CEO of the company Michael Porier.Michael โฆSee details»
Qualigen Therapeutics CEO Michael Poirier Provides Letter to โฆ
CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and โฆSee details»
Qualigen Therapeutics Chief Executive Officer Michael Poirier โฆ
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (โQualigenโ or โthe Company,โ Nasdaq: QLGN), a diversified life sciences company focused โฆSee details»
Qualigen, Inc. (Qualigen, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric โฆSee details»
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial ...
Nov 15, 2022 Qualigen Therapeutics, Inc. Q3 2022 FastPack ® sales increased approximately 25% year-over-year Company continues to execute on and advance core therapeutic โฆSee details»
Qualigen Therapeutics, Inc. Reports First Quarter 2021
May 14, 2021 Please submit questions for management no later than 10:00 a.m. EDT on Monday, May 17, 2021 to [email protected]. Speakers on the call from Qualigen will be โฆSee details»
Qualigen Therapeutics, Inc. to present at the Benzinga
CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for โฆSee details»
Qualigen Therapeutics, Inc. Announces $12 Million Registered โฆ
CARLSBAD, Calif., Dec. 16, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive โฆSee details»
Therapeutics Pipeline - Qualigen Therapeutics
Our core therapeutics pipeline includes the following programs under active development for indications within rare oncology: QN-302 and Pan-RAS. To learn more about partnering or โฆSee details»
Qualigen Therapeutics Announces Pre-IND Feedback from U.S.
CARLSBAD, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (โQualigenโ or โthe Company,โ Nasdaq: QLGN), a diversified life sciences company focused โฆSee details»
Qualigen Therapeutics Receives Positive Pre-IND Response from โฆ
Oct 28, 2020 Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19 Plans to File IND Application โฆSee details»
FastPack® IP System Orders - Qualigen Diagnostics
©2024 Qualigen Diagnostics. Contact Us; Terms of Service; Privacy Policy; Scroll to TopSee details»